The Worldwide Innovative Networking (WIN) Consortium invites you to attend the third WIN Annual Symposium, dedicated this year to the topic of 'Gateways to increasing the efficacy of cancer diagnostics and therapeutics'. Examples of questions for discussion and debate during WIN 3 include: - Determining the efficacy of targeted cancer therapies - Determining the efficacy of genetic and molecular biomarkers for selecting patients likely to respond to targeted therapeutics - Improved design of clinical trials with targeted therapies. Efficient comparisons. - Appropriate endpoints. Combinations of therapies. Is randomization necessary? - Building more effective collaborations between academia, industry and patients - Innovation in technologies that identify genetic and molecular abnormalities in cancers - Improvements in bioinformatics and applications of systems biology The conference aims to create a forum for open discussion, in which participants expertise and input from all stakeholders in cancer drug development are crucial. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside.